Accuray (ARAY) Competitors

Accuray (NASDAQ:ARAY) and Surmodics (NASDAQ:SRDX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

Do insiders and institutionals hold more shares of ARAY or SRDX?

64.1% of Accuray shares are held by institutional investors. Comparatively, 96.6% of Surmodics shares are held by institutional investors. 4.2% of Accuray shares are held by insiders. Comparatively, 8.9% of Surmodics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts prefer ARAY or SRDX?

Accuray currently has a consensus target price of $5.00, suggesting a potential upside of 221.54%. Surmodics has a consensus target price of $43.00, suggesting a potential upside of 18.46%. Given Accuray's stronger consensus rating and higher probable upside, equities analysts clearly believe Accuray is more favorable than Surmodics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accuray	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Surmodics	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Is ARAY or SRDX more profitable?

Accuray has a net margin of -0.35% compared to Surmodics' net margin of -14.59%. Surmodics' return on equity of -2.99% beat Accuray's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accuray	-0.35%	-5.79%	-0.58%
Surmodics	-14.59%	-2.99%	-1.99%

Which has higher valuation and earnings, ARAY or SRDX?

Accuray has higher revenue and earnings than Surmodics. Accuray is trading at a lower price-to-earnings ratio than Surmodics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accuray	$458.51M	0.38	-$1.59M	-$0.02	-77.75
Surmodics	$126.08M	4.12	-$11.54M	-$1.23	-29.51

Does the media refer more to ARAY or SRDX?

In the previous week, Accuray had 12 more articles in the media than Surmodics. MarketBeat recorded 16 mentions for Accuray and 4 mentions for Surmodics. Surmodics' average media sentiment score of 0.76 beat Accuray's score of 0.06 indicating that Surmodics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accuray	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Surmodics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, ARAY or SRDX?

Accuray has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500.

Summary

Accuray beats Surmodics on 8 of the 15 factors compared between the two stocks.